Category: Providers

Eli Lilly and Amgen Announce Refunds, Amgen Issues NDC Change

September 17, 2024 Bella Czajkowski, National Correspondent Views

Eli Lilly and Amgen announced refunds for 340B covered entities that purchased certain drugs in 2021.

Two drugmakers recently announced that they will refund 340B covered entities that purchased certain medications following adjustments to their ceiling [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HRSA Adds Louisiana to Eligible States for Immediate 340B Enrollment Due to Hurricane Francine

September 17, 2024 Bella Czajkowski, National Correspondent Views

HHS declared a Public Health Emergency for Louisiana following Hurricane Francine.

Louisiana providers can enroll in the 340B program outside of the formal enrollment period amid disaster relief efforts following Hurricane [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Covered Entities Threaten Action Against Drugmakers Over New Reporting Requirements

September 13, 2024 Shannon Young, Associate Editor/Senior Writer Views

Second Sight Solutions updated 340B ESP's terms of use on Oct. 4.

A law firm representing hospitals and other 340B covered entities across the U.S. has called on more than two dozen [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

State Contract Pharmacy Lawsuit Weekly Roundup: 5th Circuit Appeals and Updates in Arkansas, Minnesota, West Virginia

September 12, 2024 340B Report Staff Views

Key filings and orders occurred in lawsuits challenging the 340B contract pharmacy access law in Missouri.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AstraZeneca Tightens Contract Pharmacy Restrictions to Require Claims Data Submission

September 12, 2024 Bella Czajkowski, National Correspondent Views

AstraZeneca will discontinue a certain bottle dosage of its breast cancer drug Truqap (capiversatib) by the end of the year but allow 340B covered entities to replenish their supply with an equivalent dose in blister pack package form.

Beginning Oct. 1, AstraZeneca will tighten its 340B contract pharmacy restrictions to require claims data on 340B utilization at contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AHA Calls on Congress to Defend 340B Access to Specialty, Community Pharmacies Amid Drugmaker Resistance

September 10, 2024 Bella Czajkowski, National Correspondent Views

AHA officials penned a Medical Economics op-ed on “the truth behind growth of the 340B prescription drug program.”

Specialty and community pharmacies play an essential role in the 340B program and must be protected against interference by drug [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Merck Offers Refunds to 340B Providers for Overcharges of Inhaler in Fourth Notice This Year

September 6, 2024 William Newton, Associate Editor/Senior Writer Views

Drugmaker Merck announced it will refund 340B covered entities for certain overcharges.

Pharmaceutical manufacturer Merck has announced it will refund 340B covered entities for certain overcharges of its inhaler, Proventil HFA, during [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

J&J’s 340B Rebate Vendor to Host In-Person Training Next Monday Despite Government’s Objection to Proposal

September 4, 2024 William Newton, Associate Editor/Senior Writer Views

Beacon Channel Management is holding multiple trainings on its 340B rebate platform.

The new industry vendor administrating Johnson & Johnson’s (J&J’s) contested 340B rebate proposal is hosting an in-person training for third [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Bayer to Extend Contract Pharmacy Restrictions to Federal Grantees, Providers and Advocates Voice Concerns About Recent Trend

September 4, 2024 Shannon Young, Associate Editor/Senior Writer Views

Bayer will no longer exempt federal grantees from its 340B contract pharmacy policy as of Oct. 1.

German drugmaker Bayer will no longer exempt federal grantees from its 340B contract pharmacy policy beginning Oct. 1—the same day [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

UPDATED: Certain NDCs for Four of Ten Newly Announced Medicare Negotiated Drug Prices Are Below Current 340B Prices

September 4, 2024 William Newton, Associate Editor/Senior Writer Views

CMS announced the "maximum fair price" for the first ten drugs selected for Medicare drug price negotiations.

Certain formulations for four of the first ten drugs selected for Medicare drug price negotiations have newly negotiated prices lower [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live